NSPR—InspireMD IncEarnings
NASDAQ·Health CareData sourced from Finnhub (quotes, earnings calendar, news) and Yahoo Finance (daily closing prices). Source evidence temporarily unavailable. No upcoming date available. Read the methodology.
NSPR delayed price change and context
NSPR (InspireMD Inc) — the delayed price is temporarily unavailable. No price move or cause is inferred.
Delayed quote
Loading…
Company overview
- Sector
- Health Care
- Exchange
- NASDAQ
- Market cap
- $0.0B
- Report time
- —
InspireMD Inc is listed on NASDAQ in the health care sector. No upcoming earnings date is currently scheduled.
Price history
Loading…
Recent posts · NSPR
All postsAI Stock Analysis is a Pro feature
Get an AI-generated breakdown of every earnings setup — beat history, EPS trend, and what to watch into the print.
Unlock with ProEarnings history · EPS estimate vs actual
History temporarily unavailable
Post-earnings price reaction · last 4 quarters
1-day = close after announcement vs close before. 5-day = close 5 trading days after vs close before. Projection extrapolates average magnitude.
AI summary · latest 8-K earnings release
Generated from the latest SEC EDGAR filing
Summarizing 8-K release… first run can take 10–20s.
Catalyst timeline
Upcoming and recent market-moving events for NSPR · plus key macro context
Surprise prints repriced rate-cut odds last 3 of 4 releases. Bond yields and rate-sensitive sectors most exposed.
Highest-impact macro print of the cycle. SPX implied move 1.4%, semis 2.3%.
Latest news · NSPR
Headlines from the past 14 days · Source: Finnhub
NSPR discussion
NSPR earnings FAQ
- When does NSPR report earnings?
- InspireMD Inc (NSPR) has no upcoming provider date available here. This does not mean the company has not announced one.
- What time does NSPR report earnings?
- NSPR historically reports during quarterly earnings season. Check the calendar for the confirmed BMO or AMC time for the next print.
- What exchange is NSPR listed on?
- InspireMD Inc (NSPR) trades on the NASDAQ in the Health Care sector.
- How can I track NSPR earnings history?
- The latest two reported quarters are publicly available. Pro subscribers can access up to eight quarters and deeper analysis.
What to listen for on the NSPR earnings call
Sector- and ticker-specific items active traders track on InspireMD Inc's quarterly call — beyond the headline EPS and revenue beat.
- Headline EPS vs. consensus and the whisper number
- Revenue growth vs. guide and consensus
- Forward guidance for next quarter and full year
- Margin trend and capital-allocation commentary
About NSPR earnings
InspireMD Inc (NSPR) is a health care company listed on the NASDAQ. No next release date is available here. . Earnings Compass tracks the report time, analyst EPS and revenue consensus, and the post-release price reaction so active traders can size positions and set alerts ahead of the print.
On reporting day, the two numbers that move NSPR most are the headline EPS and the forward guidance. EPS (earnings per share) measures profit per outstanding share; a beat of analyst consensus often triggers price-target upgrades, while a miss can wipe out months of gains in a single session. The forward guidance management issues for the next quarter frequently overrides the headline — a beat-and-guide-down quarter still sells off, and a miss with a stronger outlook can rally. Active traders also watch the whisper number — the unofficial bar NSPR actually has to clear for the stock to rally on the print.
For a step-by-step playbook on parsing the release, see our guides on reading an earnings report and trading earnings season. If you're new to the calendar workflow, the earnings calendar guide covers how to filter the day's reports by sector and market cap to surface the names that actually move your book.
Add NSPR to your watchlist to receive an alert when the date is confirmed and again when results hit. You can also browse the full Health Care sector for the rest of the upcoming reports in this group, or the full earnings calendar for everything reporting this week.